et al. Chip−/−-Mouse Liver: Adiponectin-AMPK-FOXO-Activation Overrides CYP2E1-Elicited JNK1-Activation, Delaying Onset of NASH: Therapeutic Implications. The gene discussed is CYP2E1; the disease is metabolic dysfunction-associated steatohepatitis.